14-3-3 Proteins--a focus on cancer and human disease.

14-3-3 Proteins are a ubiquitous family of molecules that participate in protein kinase signaling pathways within all eukaryotic cells. Functioning as phosphoserine/phosphothreonine-binding modules, 14-3-3 proteins participate in phosphorylation-dependent protein-protein interactions that control progression through the cell cycle, initiation and maintenance of DNA damage checkpoints, activation of MAP kinases, prevention of apoptosis, and coordination of integrin signaling and cytoskeletal dynamics. In this review, we discuss the regulation of 14-3-3 structure and ligand binding, with a focus on the role of 14-3-3 proteins in human disease, particularly cancer. We discuss the latest data on the role of different 14-3-3 isotypes, the interaction of 14-3-3 proteins with Raf, Cdc25, and various integrin family members, and the likelihood that 14-3-3 proteins could be useful therapeutic targets in the treatment of human disease.

[1]  K. Xia,et al.  Interaction of the protein kinase Raf-1 with 14-3-3 proteins. , 1994, Science.

[2]  J. Pietenpol,et al.  The ΔNp63α Phosphoprotein Binds the p21 and 14-3-3σ Promoters In Vivo and Has Transcriptional Repressor Activity That Is Reduced by Hay-Wells Syndrome-Derived Mutations , 2003, Molecular and Cellular Biology.

[3]  M. Donzelli,et al.  Regulating mammalian checkpoints through Cdc25 inactivation , 2003, EMBO reports.

[4]  S. Sukumar,et al.  Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer , 2001, Oncogene.

[5]  H. Paudel,et al.  14-3-3 Connects Glycogen Synthase Kinase-3β to Tau within a Brain Microtubule-associated Tau Phosphorylation Complex* , 2003, The Journal of Biological Chemistry.

[6]  J. Guan,et al.  Identification of a novel interaction between integrin β1 and 14-3-3β , 2001, Oncogene.

[7]  M. Toyota,et al.  Inactivation of the 14-3-3 sigma gene is associated with 5' CpG island hypermethylation in human cancers. , 2000, Cancer research.

[8]  H. Paudel,et al.  14-3-3ζ Is an Effector of Tau Protein Phosphorylation* , 2000, The Journal of Biological Chemistry.

[9]  Y. Takihara,et al.  Role of the β isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation , 2000 .

[10]  T. McDonald,et al.  14‐3‐3 amplifies and prolongs adrenergic stimulation of HERG K+ channel activity , 2002, The EMBO journal.

[11]  Hui Zhao,et al.  Dual phosphorylation controls Cdc25 phosphatases and mitotic entry , 2003, Nature Cell Biology.

[12]  J. Lowe,et al.  Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins , 1996, Neuroscience Letters.

[13]  Hiromu Suzuki,et al.  Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 σ gene in human hepatocellular carcinoma , 2000, Oncogene.

[14]  S. Moreno,et al.  Replication checkpoint requires phosphorylation of the phosphatase Cdc25 by Cds1 or Chk1 , 1998, Nature.

[15]  Lubo Zhang,et al.  Effect of maternal chronic hypoxic exposure during gestation on apoptosis in fetal rat heart. , 2003, American journal of physiology. Heart and circulatory physiology.

[16]  I. Hoffmann,et al.  Ectopic Expression of Cdc25A Accelerates the G1/S Transition and Leads to Premature Activation of Cyclin E- and Cyclin A-Dependent Kinases , 1999, Molecular and Cellular Biology.

[17]  K. Sadhu,et al.  p55CDC25 is a nuclear protein required for the initiation of mitosis in human cells. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  Meenhard Herlyn,et al.  Axis of evil: molecular mechanisms of cancer metastasis , 2003, Oncogene.

[19]  D. Ledbetter,et al.  Refinement of a 400-kb critical region allows genotypic differentiation between isolated lissencephaly, Miller-Dieker syndrome, and other phenotypes secondary to deletions of 17p13.3. , 2003, American journal of human genetics.

[20]  H. Jäckle,et al.  Requirement for Drosophila 14-3-3 zeta in Raf-dependent photoreceptor development. , 1997, Genes & development.

[21]  Michele Pagano,et al.  Degradation of Cdc25A by β-TrCP during S phase and in response to DNA damage , 2003, Nature.

[22]  G. Rubin,et al.  14-3-3 epsilon positively regulates Ras-mediated signaling in Drosophila. , 1997, Genes & development.

[23]  Y. Miyagi,et al.  Forced expression of antisense 14-3-3beta RNA suppresses tumor cell growth in vitro and in vivo. , 2003, Carcinogenesis.

[24]  Hui Zhao,et al.  Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Decaprio,et al.  Cytoplasmic Localization of Human cdc25C during Interphase Requires an Intact 14-3-3 Binding Site , 1999, Molecular and Cellular Biology.

[26]  D. Morrison,et al.  14-3-3 is not essential for Raf-1 function: identification of Raf-1 proteins that are biologically activated in a 14-3-3- and Ras-independent manner , 1995, Molecular and cellular biology.

[27]  F. Révillion,et al.  Proteomic analysis reveals that 14-3-3σ is down-regulated in human breast cancer cells , 2001 .

[28]  Tianhua Niu,et al.  Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c‐Jun towards cyclin D1 , 2001, The EMBO journal.

[29]  H. Piwnica-Worms,et al.  Chk1 Kinase Negatively Regulates Mitotic Function of Cdc25A Phosphatase through 14-3-3 Binding , 2003, Molecular and Cellular Biology.

[30]  G. Borisy,et al.  Cell Migration: Integrating Signals from Front to Back , 2003, Science.

[31]  Karen Lundgren,et al.  mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2 , 1991, Cell.

[32]  A. Forrest,et al.  Cdc25B activity is regulated by 14-3-3 , 2001, Oncogene.

[33]  M. Yaffe,et al.  The Structural Basis for 14-3-3:Phosphopeptide Binding Specificity , 1997, Cell.

[34]  Anthony J. Muslin,et al.  Disruption of the 14-3-3 Binding Site within the B-Raf Kinase Domain Uncouples Catalytic Activity from PC12 Cell Differentiation* , 2000, The Journal of Biological Chemistry.

[35]  H. Baxter,et al.  Immunolocalisation of 14-3-3 isoforms in normal and scrapie-infected murine brain , 2002, Neuroscience.

[36]  M. Molinari,et al.  Human Cdc25 A inactivation in response to S phase inhibition and its role in preventing premature mitosis , 2000, EMBO reports.

[37]  K. Okazaki,et al.  Chk1 is activated transiently and targets Cdc25A for degradation at the Xenopus midblastula transition , 2002, The EMBO journal.

[38]  Paul G. Young,et al.  Phosphorylation and inactivation of the mitotic inhibitor Weel by the nim1/cdr1 kinase , 1993, Nature.

[39]  D. Morrison,et al.  Identification of the major phosphorylation sites of the Raf-1 kinase. , 1993, The Journal of biological chemistry.

[40]  P. Cohen,et al.  Phosphorylation of the Cytoplasmic Domain of the Integrin CD18 Chain by Protein Kinase C Isoforms in Leukocytes* , 2002, The Journal of Biological Chemistry.

[41]  R. Liddington,et al.  Crystal structure of the zeta isoform of the 14-3-3 protein , 1995, Nature.

[42]  M. Yaffe,et al.  Phosphoserine/threonine-binding domains. , 2001, Current opinion in cell biology.

[43]  N. Rhind,et al.  Cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. , 1997, Science.

[44]  S. Shenolikar,et al.  PP1 control of M phase entry exerted through 14‐3‐3‐regulated Cdc25 dephosphorylation , 2003, The EMBO journal.

[45]  W. Dobyns,et al.  Lissencephaly and the molecular basis of neuronal migration. , 2003, Human molecular genetics.

[46]  Tim Crook,et al.  Functional regulation of p73 and p63: development and cancer. , 2003, Trends in biochemical sciences.

[47]  S. Smerdon,et al.  Structure of a 14-3-3 protein and implications for coordination of multiple signalling pathways , 1995, Nature.

[48]  K. Irie,et al.  Synergistic activation by Ras and 14-3-3 protein of a mitogen-activated protein kinase kinase kinase named Ras-dependent extracellular signal-regulated kinase kinase stimulator. , 1994, The Journal of biological chemistry.

[49]  Jonathan Cooper,et al.  A Novel Sphingosine-dependent Protein Kinase (SDK1) Specifically Phosphorylates Certain Isoforms of 14-3-3 Protein* , 1998, The Journal of Biological Chemistry.

[50]  H. Piwnica-Worms,et al.  14-3-3 binding regulates catalytic activity of human Wee1 kinase. , 2001, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[51]  N. Mailand,et al.  Rapid destruction of human Cdc25A in response to DNA damage. , 2000, Science.

[52]  T. Veenstra,et al.  Protein Phosphatase 2A Positively Regulates Ras Signaling by Dephosphorylating KSR1 and Raf-1 on Critical 14-3-3 Binding Sites , 2003, Current Biology.

[53]  Mong-Hong Lee,et al.  Association of the Cyclin-dependent Kinases and 14-3-3 Sigma Negatively Regulates Cell Cycle Progression* , 2000, The Journal of Biological Chemistry.

[54]  J. Raleigh,et al.  The G(2) DNA damage checkpoint targets both Wee1 and Cdc25. , 2000, Journal of cell science.

[55]  H. Piwnica-Worms,et al.  DNA Damage and Replication Checkpoints in Fission Yeast Require Nuclear Exclusion of the Cdc25 Phosphatase via 14-3-3 Binding , 1999, Molecular and Cellular Biology.

[56]  D. Ledbetter,et al.  14-3-3ε is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller–Dieker syndrome , 2003, Nature Genetics.

[57]  D. Campbell,et al.  14-3-3-affinity purification of over 200 human phosphoproteins reveals new links to regulation of cellular metabolism, proliferation and trafficking. , 2004, The Biochemical journal.

[58]  K. Isselbacher,et al.  Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome. , 1999, Science.

[59]  P. Rauch,et al.  Human p14ARF-mediated cell cycle arrest strictly depends on intact p53 signaling pathways , 2002, Oncogene.

[60]  F. D. Carlson.  Physiological and Biochemical Aspects of Nervous Integration , 1968 .

[61]  B. Gusterson,et al.  Coincident inactivation of 14-3-3σ and p16INK4a is an early event in vulval squamous neoplasia , 2002, Oncogene.

[62]  T. Pandita,et al.  High frequency of hypermethylation at the 14-3-3 sigma locus leads to gene silencing in breast cancer. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[63]  K. Kinzler,et al.  14-3-3σ Is a p53-Regulated Inhibitor of G2/M Progression , 1997 .

[64]  S. Elledge,et al.  Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25. , 1997, Science.

[65]  A. Kumagai,et al.  Binding of 14-3-3 proteins and nuclear export control the intracellular localization of the mitotic inducer Cdc25. , 1999, Genes & development.

[66]  J. Hancock,et al.  Protein phosphatases 1 and 2A promote Raf-1 activation by regulating 14-3-3 interactions , 2001, Oncogene.

[67]  Bruce Tidor,et al.  Proteomic Identification of 14-3-3ζ as a Mitogen-Activated Protein Kinase-Activated Protein Kinase 2 Substrate: Role in Dimer Formation and Ligand Binding , 2003, Molecular and Cellular Biology.

[68]  A. Nicholson,et al.  Mutations of the BRAF gene in human cancer , 2002, Nature.

[69]  Jun Qin,et al.  SCFbeta-TRCP links Chk1 signaling to degradation of the Cdc25A protein phosphatase. , 2003, Genes & development.

[70]  D. Berg,et al.  14-3-3 proteins in the nervous system , 2003, Nature Reviews Neuroscience.

[71]  S. Kornbluth,et al.  Maintenance of G2 arrest in the Xenopus oocyte: a role for 14‐3‐3‐mediated inhibition of Cdc25 nuclear import , 1999, The EMBO journal.

[72]  David B. Goldstein,et al.  Demography, Recombination Hotspot Intensity, and the Block Structure of Linkage Disequilibrium , 2003, Current Biology.

[73]  Arnoud Sonnenberg,et al.  Integrins in regulation of tissue development and function , 2003, The Journal of pathology.

[74]  N. Walworth,et al.  Phosphorylation activates Chk1 and is required for checkpoint-mediated cell cycle arrest , 2002, Journal of Cell Science.

[75]  K. Kinzler,et al.  14-3-3σ is required to prevent mitotic catastrophe after DNA damage , 1999, Nature.

[76]  Jun Zhu,et al.  14-3-3 proteins; bringing new definitions to scaffolding , 2001, Oncogene.

[77]  P. Graves,et al.  14-3-3 Proteins Are Required for Maintenance of Raf-1 Phosphorylation and Kinase Activity , 1998, Molecular and Cellular Biology.

[78]  E. Stavridi,et al.  ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins , 1998, Nature Genetics.

[79]  R. Knight,et al.  p63 and p73 transactivate differentiation gene promoters in human keratinocytes. , 2000, Biochemical and biophysical research communications.

[80]  G. Boss,et al.  Cell Type-specific Regulation of B-Raf Kinase by cAMP and 14-3-3 Proteins* , 2000, The Journal of Biological Chemistry.

[81]  S. Reed,et al.  Human F-box protein hCdc4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line , 2001, Nature.

[82]  B. Hoffman,et al.  Cdc25A stability is controlled by the ubiquitin-proteasome pathway during cell cycle progression and terminal differentiation , 2000, Oncogene.

[83]  S. Elledge,et al.  Linkage of ATM to cell cycle regulation by the Chk2 protein kinase. , 1998, Science.

[84]  S. Masters,et al.  14-3-3 proteins: structure, function, and regulation. , 2000, Annual review of pharmacology and toxicology.

[85]  W. Kolch,et al.  Regulation of Raf‐1 kinase activity by the 14‐3‐3 family of proteins. , 1995, The EMBO journal.

[86]  D Cowburn,et al.  Modular peptide recognition domains in eukaryotic signaling. , 1997, Annual review of biophysics and biomolecular structure.

[87]  F. McCormick,et al.  Binding of 14-3-3 proteins to the protein kinase Raf and effects on its activation. , 1994, Science.

[88]  P. Marchisio,et al.  The MSP Receptor Regulates α6β4 and α3β1 Integrins via 14-3-3 Proteins in Keratinocyte Migration , 2003 .

[89]  G. Berruti.  A novel rap1/B-Raf/14-3-3 theta protein complex is formed in vivo during the morphogenetic differentiation of postmeiotic male germ cells. , 2000, Experimental cell research.

[90]  Daniel A. Haber,et al.  Archipelago regulates Cyclin E levels in Drosophila and is mutated in human cancer cell lines , 2001, Nature.

[91]  K. Vuori,et al.  Cell Adhesion Regulates the Interaction between the Docking Protein p130Cas and the 14-3-3 Proteins* , 1999, The Journal of Biological Chemistry.

[92]  R. Marais,et al.  14-3-3 Antagonizes Ras-Mediated Raf-1 Recruitment to the Plasma Membrane To Maintain Signaling Fidelity , 2002, Molecular and Cellular Biology.

[93]  K. Kinzler,et al.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage. , 1998, Science.

[94]  R. Ghirlando,et al.  Crystal Structure of the 14-3-3ζ:Serotonin N-Acetyltransferase Complex A Role for Scaffolding in Enzyme Regulation , 2001, Cell.

[95]  J. Celis,et al.  Expression of the Tumor Suppressor Protein 14-3-3σ Is Down-regulated in Invasive Transitional Cell Carcinomas of the Urinary Bladder Undergoing Epithelial-to-Mesenchymal Transition* , 2004, Molecular & Cellular Proteomics.

[96]  Michael B Yaffe,et al.  How do 14‐3‐3 proteins work? – Gatekeeper phosphorylation and the molecular anvil hypothesis , 2002, FEBS letters.

[97]  S. Reed,et al.  hCDC4 gene mutations in endometrial cancer. , 2002, Cancer research.

[98]  T Pawson,et al.  SH2 and SH3 domains , 1993, Current Biology.

[99]  S. Howell,et al.  14-3-3 alpha and delta are the phosphorylated forms of raf-activating 14-3-3 beta and zeta. In vivo stoichiometric phosphorylation in brain at a Ser-Pro-Glu-Lys MOTIF. , 1995, The Journal of biological chemistry.

[100]  J. Hancock,et al.  Interactions of c-Raf-1 with phosphatidylserine and 14-3-3 , 1999, Oncogene.

[101]  Chung,et al.  The 14-3-3 proteins: cellular regulators of plant metabolism. , 1999, Trends in plant science.

[102]  P. Russell,et al.  Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein , 1999, Nature.

[103]  P. van der Hoeven,et al.  14-3-3 isotypes facilitate coupling of protein kinase C-zeta to Raf-1: negative regulation by 14-3-3 phosphorylation. , 2000, The Biochemical journal.

[104]  S. Howell,et al.  14-3-3 proteins: biological function and domain structure. , 1995, Biochemical Society transactions.

[105]  A. Eychène,et al.  Identification of signalling proteins interacting with B-Raf in the yeast two-hybrid system. , 1996, Oncogene.

[106]  Joseph Avruch,et al.  A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity , 1998, Nature.

[107]  N. Cairns,et al.  Increased levels of 14-3-3 gamma and epsilon proteins in brain of patients with Alzheimer's disease and Down syndrome. , 1999, Journal of neural transmission. Supplementum.

[108]  H. Paudel.  Phosphorylation by Neuronal cdc2-like Protein Kinase Promotes Dimerization of Tau Protein in Vitro * , 1997, The Journal of Biological Chemistry.

[109]  H. Piwnica-Worms,et al.  The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex , 1997, Molecular and cellular biology.

[110]  Anthony J. Muslin,et al.  14‐3‐3 proteins block apoptosis and differentially regulate MAPK cascades , 2000, The EMBO journal.

[111]  Mong-Hong Lee,et al.  14-3-3σ Positively Regulates p53 and Suppresses Tumor Growth , 2003, Molecular and Cellular Biology.

[112]  A. Kumagai,et al.  Positive regulation of Wee1 by Chk1 and 14-3-3 proteins. , 2001, Molecular biology of the cell.

[113]  Petr Herman,et al.  14-3-3ζ C-terminal Stretch Changes Its Conformation upon Ligand Binding and Phosphorylation at Thr232* , 2004, Journal of Biological Chemistry.

[114]  C. Peng,et al.  Mitotic and G2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of Cdc25C on serine-216. , 1997, Science.

[115]  P. Graves,et al.  Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding , 2001, Oncogene.

[116]  G. Tzivion,et al.  Regulation of the Raf-1 kinase domain by phosphorylation and 14-3-3 association. , 2000, The Biochemical journal.

[117]  P. Allen,et al.  Interaction of 14-3-3 with Signaling Proteins Is Mediated by the Recognition of Phosphoserine , 1996, Cell.

[118]  A. Sonnenberg,et al.  Erratum: Integrins in regulation of tissue development and function. J Pathol; 200: 471–480 , 2003 .

[119]  C. Der,et al.  14-3-3 ζ Negatively Regulates Raf-1 Activity by Interactions with the Raf-1 Cysteine-rich Domain* , 1997, The Journal of Biological Chemistry.

[120]  D. Sivam,et al.  Identification of Genes Overexpressed in Head and Neck Squamous Cell Carcinoma Using a Combination of Complementary DNA Subtraction and Microarray Analysis , 2000, The Laryngoscope.

[121]  Joseph Avruch,et al.  Significance of 14-3-3 self-dimerization for phosphorylation-dependent target binding. , 2003, Molecular biology of the cell.

[122]  R. McPherson,et al.  14-3-3 Facilitates Ras-Dependent Raf-1 Activation In Vitro and In Vivo , 1998, Molecular and Cellular Biology.

[123]  G. Lubec,et al.  Aberrant expression of signaling‐related proteins 14‐3‐3 gamma and RACK1 in fetal Down Syndrome brain (trisomy 21) , 2002, Electrophoresis.

[124]  C. Peng,et al.  C-TAK1 protein kinase phosphorylates human Cdc25C on serine 216 and promotes 14-3-3 protein binding. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[125]  K. Irie,et al.  Stimulatory effects of yeast and mammalian 14-3-3 proteins on the Raf protein kinase. , 1994, Science.

[126]  Sam W. Lee,et al.  PIN1 Is an E2F Target Gene Essential for Neu/Ras-Induced Transformation of Mammary Epithelial Cells , 2002, Molecular and Cellular Biology.

[127]  D. Beach,et al.  Involvement of a type 1 protein phosphatase encoded by bws1 + in fission yeast mitotic control , 1989, Cell.

[128]  N. Dumaz,et al.  Protein Kinase A Blocks Raf-1 Activity by Stimulating 14-3-3 Binding and Blocking Raf-1 Interaction with Ras* , 2003, Journal of Biological Chemistry.

[129]  K. Titani,et al.  The signal modulator protein 14-3-3 is a target of sphingosine- or N,N-dimethylsphingosine-dependent kinase in 3T3(A31) cells. , 1995, Biochemical and biophysical research communications.

[130]  Satoshi Inoue,et al.  Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth , 2002, Nature.

[131]  M. Roussel,et al.  A rate limiting function of cdc25A for S phase entry inversely correlates with tyrosine dephosphorylation of Cdk2 , 1999, Oncogene.

[132]  M. Yaffe.  Phosphotyrosine-binding domains in signal transduction , 2002, Nature Reviews Molecular Cell Biology.

[133]  D. Shakes,et al.  Molecular evolution of the 14-3-3 protein family , 1996, Journal of Molecular Evolution.

[134]  Y. Wang,et al.  Binding of 14-3-3beta to the carboxyl terminus of Wee1 increases Wee1 stability, kinase activity, and G2-M cell population. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[135]  Alastair Aitken,et al.  Functional specificity in 14-3-3 isoform interactions through dimer formation and phosphorylation. Chromosome location of mammalian isoforms and variants. , 2002, Plant Molecular Biology.

[136]  W. Fantl,et al.  Activation of Raf-1 by 14-3-3 proteins , 1994, Nature.

[137]  M. Gambello,et al.  14-3-3epsilon is important for neuronal migration by binding to NUDEL: a molecular explanation for Miller-Dieker syndrome: a molecular explanation for Miller-Dieker syndrome , 2003 .

[138]  S R Datta,et al.  14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. , 2000, Molecular cell.

[139]  E. Stavridi,et al.  Substitutions that compromise the ionizing radiation-induced association of p53 with 14-3-3 proteins also compromise the ability of p53 to induce cell cycle arrest. , 2001, Cancer research.

[140]  Anthony J. Muslin,et al.  14-3-3 proteins: regulation of subcellular localization by molecular interference. , 2000, Cellular signalling.